Article Details
Retrieved on: 2024-08-13 16:21:54
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the development of a cell therapy, pz-cel, aimed at healing patients with Epidermolysis Bullosa Dystrophica, a collagen disease. CMS and FDA involvement highlight the regulatory steps towards its approval, supporting better treatment options.
Article found on: www.managedhealthcareexecutive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here